5, 6, or 7-substituted-S- (hetero)arylisoquinolinamine derivatives as antitumor agents

Details for Australian Patent Application No. 2012203232 (hide)

Owner Rexahn Pharmaceuticals, Inc.

Inventors Lee, Young Bok; Ahn, Chang-ho; Cho, Won-jea

Agent Freehills

Pub. Number AU-A-2012203232

Parent 2007322068

Filing date 31 May 2012

Wipo publication date 21 June 2012

International Classifications

C07D 217/22 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/472 - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4725

A61P 35/00 Antineoplastic agents

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 491/04 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

14 June 2012 Complete Application Filed

21 June 2012 Application Open to Public Inspection

  Published as AU-A-2012203232

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203233-A method of installing a buoy and apparatus for tensioning a buoy to an anchoring location

2012203231-Heliostat control